BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
US |
|
M
|
MFE-MEDIAFOREUROPE NV
F:T0J0
|
IT |
|
S
|
Sage Group PLC
OTC:SGPYY
|
UK |
|
I
|
Ikegps Group Ltd
ASX:IKE
|
NZ |
|
Microvast Holdings Inc
NASDAQ:MVST
|
US |
|
Kopran Ltd
NSE:KOPRAN
|
IN |
|
Y
|
Yoshiharu Global Co
NASDAQ:YOSH
|
US |
|
G
|
G Enone Energy Co Ltd
KOSDAQ:270520
|
KR |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
SWB:MUV2
|
DE |
|
InPost SA
AEX:INPST
|
LU |
|
Puma SE
F:PUMA
|
DE |
|
S
|
SoftBank Corp
OTC:SOBKY
|
JP |
|
Metaplanet Inc
OTC:MTPLF
|
JP |
|
Prada SpA
HKEX:1913
|
IT |
|
O
|
Origin Energy Ltd
OTC:OGFGF
|
AU |
|
Air Lease Corp
NYSE:AL
|
US |
|
Coromandel International Ltd
NSE:COROMANDEL
|
IN |
Bankruptcy Probability
BioCryst Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioCryst Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
|
2.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
191.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
156.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
64.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
38.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioCryst Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioCryst Pharmaceuticals Inc has total debt of 803.6m USD. This includes both short-term (0 USD) and long-term (803.6m USD) debt.
You can find a full breakdown on its Balance Sheet.
